Kimia Biosciences (KIMIABL) | Stock Overview & Key Data

Kimia Biosciences Ltd. | Small-cap | Healthcare

₹37.38

-2.81%

Kimia Biosciences vs Sun Pharmaceutical Kimia Biosciences vs Divi's Laboratories Kimia Biosciences vs Sun Pharma Advanced Kimia Biosciences vs Aarti Drugs Kimia Biosciences vs Sequent Scientific Kimia Biosciences vs NIFTY 50 | Market

Chart Range Statistics Financials Returns Ownership Calculator FAQ

Kimia Biosciences Performance Comparison

Loading chart data...

Performance Summary

Interactive charts require JavaScript. Here's the essential performance data:

Period	Kimia Biosciences	Healthcare Sector	NIFTY 50
1 Week	-9.91%	N/A	N/A
1 Month	-46.83%	N/A	N/A
3 Months	-11.00%	N/A	N/A
6 Months	-22.70%	N/A	N/A
1 Year	-25.48%	N/A	N/A
3 Years	-7.70%	N/A	N/A
5 Years	-10.25%	N/A	N/A

Stock Range

Today's Range

Low: ₹36.54 High: ₹40.00

on August 22, 2025

52 Week Range

Low: ₹35.10 High: ₹86.85

on April 15, 2025

All-Time High: ₹86.85 on July 2, 2025

Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights

Key Statistics

Market Cap i INR2.0B

EPS i N/A

P/E Ratio (TTM) i N/A

Forward P/E i N/A

P/B Ratio i 18.95

PEG Ratio i N/A

Div. Yield i N/A

ROE i N/A

Beta i 1.139

Debt to Equity i 394.92

Financial Highlights

Profitability

Gross Margin i N/A

Operating Margin i 6.75%

Profit Margin i 7.31%

Returns and Earnings

Return on Assets (TTM) i N/A

Return on Equity (TTM) i N/A

EBITDA i INR188.6M

Net Income (TTM) i INR87.8M

Growth

Revenue (TTM) i

Revenue Per Share (TTM) i INR25.39

Quarterly Revenue Growth (YoY) i 5.30%

Quarterly Earnings Growth (YoY) i -58.00%

Peer Performance Comparison

Performance comparison table showing returns for peer companies over various time periods
Company	Market Cap	1W	1M	3M	6M	YTD	1Y	3Y	5Y
Kimia Biosciences KIMIABL	1.97B Small-cap	-9.91%	-46.83%	-11.00%	-22.70%	-16.69%	-25.48%	-7.70%	-10.25%
Sun Pharmaceutical SUNPHARMA	3.92T Large-cap	0.56%	-2.16%	-4.47%	0.14%	-13.13%	-7.54%	86.54%	195.42%
Divi's Laboratories DIVISLAB	1.63T Large-cap	-0.21%	-6.98%	-5.91%	7.87%	1.29%	26.68%	71.47%	87.96%
Sun Pharma Advanced SPARC	47.77B Small-cap	1.72%	-7.23%	-10.11%	14.74%	-27.21%	-34.43%	-37.13%	-23.18%
Aarti Drugs AARTIDRUGS	42.99B Small-cap	-4.13%	-10.00%	1.76%	27.10%	6.05%	-14.34%	10.27%	-34.08%
Sequent Scientific SEQUENT	44.30B Small-cap	0.12%	-6.92%	-2.35%	12.64%	-4.77%	5.41%	52.52%	30.60%

Ownership & Short Interest

Insider Ownership i 91.96%

Institutional Ownership i 0.00%

Shares Short i N/A

Short Ratio i N/A

Short % of Shares Outstanding i N/A

Average 10-Day Volume i 17K

Average 90-Day Volume i 11K

Kimia Biosciences Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in Kimia Biosciences would have performed over time.

Calculator Requires JavaScript

The investment calculator requires JavaScript to perform real-time calculations. Please enable JavaScript for the full experience.

Alternative: Manual Calculation

For historical performance data of Kimia Biosciences, please visit the price history page to analyze returns manually.

Recent Performance Summary:

1 Week: -9.91%
1 Month: -46.83%
3 Months: -11.00%
1 Year: -25.48%

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

What is KIMIABL's 52-week high and low?

In the last 52 weeks, Kimia Biosciences reached a high of ₹86.85 (on N/A) and a low of ₹35.10 (on April 15, 2025).

What is the market cap and P/E ratio for KIMIABL?

Curious about Kimia Biosciences's size and valuation? Its market capitalization stands at 1.97B. When it comes to valuation, the P/E ratio (trailing twelve months) is N/A, and the forward P/E (looking ahead) is N/A.

Does KIMIABL pay dividends? If so, what's the yield?

As for dividends, Kimia Biosciences isn't currently offering a significant yield, or that specific data isn't available right now.

Who are Kimia Biosciences's main competitors or similar companies to consider before investing?

When looking at Kimia Biosciences, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

Company	Mkt Cap	Sector	Industry	1Y Return	3Y Return
Sun Pharmaceutical SUNPHARMA	3.92T	Healthcare	Drug Manufacturers - Specialty & Generic	-7.54%	86.54%
Divi's Laboratories DIVISLAB	1.63T	Healthcare	Drug Manufacturers - Specialty & Generic	26.68%	71.47%
Sun Pharma Advanced SPARC	47.77B	Healthcare	Drug Manufacturers - Specialty & Generic	-34.43%	-37.13%
Aarti Drugs AARTIDRUGS	42.99B	Healthcare	Drug Manufacturers - Specialty & Generic	-14.34%	10.27%
Sequent Scientific SEQUENT	44.30B	Healthcare	Drug Manufacturers - Specialty & Generic	5.41%	52.52%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

What are the key financial health indicators for Kimia Biosciences Ltd.? (e.g., ROE, Debt/Equity)

To get a sense of Kimia Biosciences's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is N/A, the Debt to Equity ratio from the most recent quarter is 394.92, and its Gross Profit Margin stands at N/A.

What is the recent revenue and earnings growth for KIMIABL?

Looking at Kimia Biosciences's growth, its revenue over the trailing twelve months (TTM) was INR1B. Compared to the same quarter last year (YoY), quarterly revenue grew by 5.30%, and quarterly earnings saw a YoY growth of -58.00%.

How much of KIMIABL stock is held by insiders and institutions?

Wondering who owns Kimia Biosciences stock? Company insiders (like executives and directors) hold about 91.96% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.